Ikarian Capital is a biotech investment firm that focuses on innovation in drug discovery and development. Inspired by the longevity of Ikaria, the Greek island with the largest number of centenarians in the world, we strive to support companies pursuing cutting-edge science in the field of biotechnology. Led by a team of professionals with extensive scientific and biotech-specific finance backgrounds, we carefully select companies engaged in early- to late-stage clinical trials, regardless of indication, market cap, or geography.

Our expertise in this space allows us to provide long-term support to emerging companies and help them realize the potential of breakthrough science as they progress through the clinic. With a proprietary process that emphasizes selectivity and contrarian thinking, we pride ourselves on our ability to identify companies with sound business fundamentals. We are committed to building an enduring business with strong values and high ethical standards.

If you want to join us on this exciting journey or learn more about our work, please reach out to us at ir@ikariancapital. com